Red Sox face critical offseason decisions, including Bregman's opt-out and outfield moves, as they seek to bolster their lineup and manage roster depth.
Advance Auto Parts beats expectations, raises guidance, and announces major restructuring to improve profitability.
Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.
Red Sox face critical offseason decisions, including Bregman's opt-out and outfield moves, as they seek to bolster their lineup and manage roster depth.
Advance Auto Parts beats expectations, raises guidance, and announces major restructuring to improve profitability.
Eli Lilly posts blowout Q3 results, raises 2025 outlook, and sees strong demand for its GLP-1 medicines.